OBDS - On Body Delivery System
Product Description
LTS-Lohmann Therapie-System AG
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Categories
LTS-Lohmann Therapie-System AG
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
More Products from LTS-Lohmann Therapie-System AG (4)
-
Product MAP - Microneedle Array Patches
Microneedle Array Patches (MAP) from LTS are designed to enhance delivery through the intradermal route delivering a wide range of APIs including biologics and vaccines.
MAP use tiny needles that penetrate the top layer of skin, dissolve and release their active ingredients. Our MAP platform is based ... -
Product TOPS - Topical Patch Systems
Topical Patch Systems (TOPS) from LTS is a flexible, ready to use platform designed to deliver a range of topical therapies, while avoiding first-pass metabolism and improving drug efficacy. With teams of experts on hand across the globe, we are here to support your next innovative drug delivery developmen... -
Product TTS - Transdermal Therapeutic System
Transdermal Therapeutic Systems (TTS) from LTS is a proven, yet flexible, ready to use platform designed to deliver a range of active substances.
TTS are pharmaceutical patches which are applied to the skin. The active substance enters into the bloodstream transdermally and acts where it's needed.
... -
Product OTF - Oral Thin Films
Oral thin films are loaded with active substances. The Thin films are taken orally and dissolve immediately in the mouth or are applied to the mucosa. For transmucosal films, the active substance enters the bloodstream directly via the oral mucosa, without having to first pass through the gastrointestinal ...
LTS-Lohmann Therapie-System AG resources (1)
-
News LTS receives grant of $1.2 Million to support the development of thermostable mRNA in microneedles
LTS has received a grant from the Bill & Melinda Gates Foundation that will support new formulation methods for mRNA, such as dissolvable microneedle array patches (MAPs), to increase the thermostability of the overall product for its use in low- and middle-income countries (LMICs), especially in hard-to-reach conditions.